2024-03-06 12:43:15 ET
Xeris Biopharma Holdings Inc. (XERS)
Q4 2023 Earnings Conference Call
March 6, 2024 8:30 am ET
Company Participants
Paul Edick - Chairman, Chief Executive Officer
Steve Pieper - Chief Financial Officer
Allison Wey - Senior Vice President, Investor Relations
Conference Call Participants
Oren Livnat - HC Wainwright
Glen Santangelo - Jefferies
Chase Knickerbocker - Craig Hallum
Roanna Ruiz - Leerink Partners
David Amsellem - Piper Sandler
Presentation
Operator
Hello everyone and welcome to the Xeris fourth quarter and full year 2023 financial results conference call and webcast. My name is Emily and I’ll be coordinating your call today.
After the presentation, there will be the opportunity for you to ask any questions, which you can do by pressing star followed by the number one on your telephone keypad.
I’ll now turn the call over to Allison Wey, Senior Vice President of Investor Relations. Please go ahead.
Allison Wey
Thank you Emily. Good morning and welcome to Xeris Biopharma’s fourth quarter and full year 2023 financial results and conference call.
This morning we issued two press releases, one on the company’s financial results and the other on refinancing our debt facility with Hayfin Capital. Both can be found on our website....
Read the full article on Seeking Alpha
For further details see:
Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript